S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
S&P 500   3,951.57
DOW   32,244.58
QQQ   305.97
5 Tech Stocks With Bank-Like Dividend Yields
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
First Republic Bank Hits New Low, Dimon Pushes for More Cash
GBTC: The One Place to Buy Bitcoin for 58 Cents on the Dollar
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Mullen Automotive: Investment? No. Compelling Speculation, Yes 
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
General Mills Retreats To Buy Zone Ahead Of Earnings 
OTCMKTS:NVZMF

Novozymes A/S - NVZMF Competitors

$49.82
+0.96 (+1.96%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$49.49
$49.82
50-Day Range
$47.22
$53.00
52-Week Range
$38.16
$70.50
Volume
411 shs
Average Volume
3,174 shs
Market Capitalization
N/A
P/E Ratio
6.21
Dividend Yield
3.61%
Price Target
N/A

NVZMF vs. TRSBF, ATTBF, ABCZF, ADOIF, AIMDW, AGNPF, AKBLF, LBTSF, ALPX, and DRTSW

Should you be buying Novozymes A/S stock or one of its competitors? The main competitors of Novozymes A/S include 3SBio (TRSBF), Abattis Bioceuticals (ATTBF), Abcam (ABCZF), Adocia (ADOIF), Ainos (AIMDW), Algernon Pharmaceuticals (AGNPF), ALK-Abelló A/S (AKBLF), Almirall (LBTSF), Alopexx (ALPX), and Alpha Tau Medical (DRTSW). These companies are all part of the "biotechnology" industry.

Novozymes A/S vs.

Novozymes A/S (OTCMKTS:NVZMF) and 3SBio (OTCMKTS:TRSBF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novozymes A/SN/AN/AN/A$8.026.21
3SBioN/AN/AN/AN/AN/A

In the previous week, 3SBio's average media sentiment score of 0.98 beat Novozymes A/S's score of 0.00 indicating that 3SBio is being referred to more favorably in the news media.

Company Overall Sentiment
Novozymes A/S Neutral
3SBio Positive

Company Net Margins Return on Equity Return on Assets
Novozymes A/S N/A N/A N/A
3SBio N/A N/A N/A

Novozymes A/S received 41 more outperform votes than 3SBio when rated by MarketBeat users.

CompanyUnderperformOutperform
Novozymes A/SOutperform Votes
41
56.94%
Underperform Votes
31
43.06%
3SBioN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Novozymes A/S
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
3SBio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

20.4% of Novozymes A/S shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Novozymes A/S beats 3SBio on 2 of the 3 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVZMF vs. The Competition

MetricNovozymes A/SBiotechnology IndustryMedical SectorOTCMKTS Exchange
Market CapN/A$179.60M$4.26B$7.05B
Dividend Yield0.72%2.55%5.98%18.10%
P/E Ratio6.21365.69152.038.96
Price / SalesN/A22,903.723,583.00289.32
Price / CashN/A10.6926.4719.41
Price / BookN/A5.514.427.38
Net IncomeN/A-$19.02M$115.31M$727.60M
7 Day Performance4.34%-1.00%-2.76%-0.71%
1 Month Performance-0.64%-5.58%-6.79%-2.15%
1 Year Performance-24.27%15.45%-15.12%-8.53%

Novozymes A/S Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRSBF
3SBio
0 of 5 stars
$0.80
flat
N/AN/A$0.00N/A0.005,292
ATTBF
Abattis Bioceuticals
0 of 5 stars
N/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
ABCZF
Abcam
0 of 5 stars
C$13.50
flat
N/AN/AC$0.00N/A79.321,650Gap Down
ADOIF
Adocia
0 of 5 stars
C$8.87
flat
C$11.00
+24.0%
N/AC$0.00N/A0.00N/A
AIMDW
Ainos
0 of 5 stars
$0.44
+37.5%
N/AN/A$0.00$2.51M0.00N/APositive News
Gap Up
High Trading Volume
AGNPF
Algernon Pharmaceuticals
0 of 5 stars
$0.40
flat
N/A-63.6%$0.00N/A0.00N/A
AKBLF
ALK-Abelló A/S
0 of 5 stars
$14.00
flat
$150.00
+971.4%
N/A$0.00N/A0.002,537
LBTSF
Almirall
1.4754 of 5 stars
$9.68
flat
$11.50
+18.8%
N/A$0.00N/A-129.321,786Positive News
ALPX
Alopexx
0 of 5 stars
N/AN/AN/A$0.00N/A0.00N/APositive News
High Trading Volume
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.35
flat
N/AN/A$0.00N/A0.00N/A
This page (OTCMKTS:NVZMF) was last updated on 3/21/2023 by MarketBeat.com Staff